Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein with KRAB and SCAN domains 3 (ZKSCAN3) is a multifunctional transcription factor characterized by DNA-binding C2H2 zinc finger motifs, a KRAB (Krüppel-associated box) repression domain responsible for recruiting co-repressor complexes, and a SCAN domain involved in protein–protein interactions[1][2]. ZKSCAN3 acts as a master repressor of autophagy and lysosomal function by binding to promoter regions of autophagy-related genes and inhibiting their transcription, particularly under nutrient-replete conditions[1][2][3]. Under cellular stress or nutrient deprivation, ZKSCAN3 is exported from the nucleus, relieving repression and permitting autophagic activity[1][2]. It maintains genomic stability, modulates cell proliferation, and dynamically responds to post-translational modifications such as phosphorylation and ubiquitination[1]. Functionally, ZKSCAN3 displays context-dependent roles in tumorigenesis, acting as a tumor suppressor in early stages (preventing genomic instability and EMT) and an oncogene in advanced cancers (promoting metastasis and resistance)[1]. It is also implicated in controlling erythroid lineage differentiation, stem cell homeostasis, and cardiac remodeling[1]. The complexity, redundancy with related proteins, and context-specific functional duality present both opportunities and challenges for therapeutic targeting and biomarker applications.
No approved small-molecule inhibitors or drugs are currently known; therapeutic potential is proposed via modulation of ZKSCAN3–regulated transcriptional pathways or epigenetic networks[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein with KRAB and SCAN domains 3 (ZKSCAN3).